Summary
Latest filing:
Tammy Furlong is CHIEF FINANCIAL OFFICER of Elevation Oncology, Inc. (ELEV). 2 SEC Form 4 filings on record going back to 2024, most recently on 23 July 2025.
Recent Transactions
3Every recent SEC Form 4 transaction Tammy Furlong has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Tammy Furlong's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Bihua Chen - $46.87M of MLTX open-market activity in the last 12 months
- Matthew Gline - $46.22M of ROIV open-market activity in the last 12 months
- Larry Robbins - $46.04M of BFLY open-market activity in the last 12 months
- Michael John Kazley - $45.65M of SDEV open-market activity in the last 12 months
- R01 Fund LP - $45.65M of SDEV open-market activity in the last 12 months
- Brian Taylor Slingsby - $43.35M of MLYS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Tammy Furlong?
Tammy Furlong is a corporate insider, tracked as CHIEF FINANCIAL OFFICER of Elevation Oncology, Inc. (ELEV). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Tammy Furlong last file a Form 4?
The most recent primary Form 4 on record is dated 23 July 2025, one of 2 filings going back to 2024.
Where can I see all of Tammy Furlong's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Tammy Furlong and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
